The ketogenic diet (KD) is an efficacious therapy for medically refractory childhood epilepsy that also slows weight gain. We tested the hypothesis that the KD slows weight gain via neurohormones involved in energy homeostasis. We found that juvenile rodents fed a KD had slower weight gain than those fed a standard diet (SD). Rats fed a KD had higher serum leptin levels and lower insulin levels compared with those fed an SD. We investigated the increase in leptin further because this change was the only one consistent with slower weight gain. Although rats fed the SD experienced slower weight gain when calorie restricted, they had serum leptin levels similar to those fed the SD ad libitum. Furthermore, leptin deficient (ob/ob) and leptin receptor deficient (db/db) mice did not show slower weight gain on the KD. All animals on the KD had elevated serum ␤-hydroxybutyrate (␤HB) levels. Thus, ketosis is insufficient and a functioning leptin signaling system appears necessary for the KD to slow weight gain. The increase in leptin may contribute to the anticonvulsant effects of the KD. F ew treatment options exist for the 20 -30% of epileptic children whose seizures are refractory to medication. One option is the KD, a high-fat, low-carbohydrate, and adequate protein diet. The KD is remarkably effective in children with medically refractory epilepsy as 5-10% become seizure free and 30% have a Ͼ90% reduction in seizure frequency (1). Yet, its adverse effects and the parental effort involved in implementing and maintaining the diet limit its use. Thus, all epileptic children would benefit from a simpler method of attaining the diet's anticonvulsant effects, which requires elucidating its mechanism of action.
densitometer and software (GE Lunar, Madison, WI) under ketamine (40 mg/kg) and xylazine (10 mg/kg) anesthesia.
Assays. Serum glucose concentrations were measured using a glucometer. Serum ␤HB concentrations were determined enzymatically except as shown in Figure 3 in which the KetoSite Test Kit (Stanbio Laboratory, Boerne, TX) and STAT-Site analyzer (GDS Diagnostics, Elkhart, IN) were used. Enzymatically determined values typically were higher. Serum cortisol, ghrelin, insulin, and leptin levels were determined by radioimmunoassay (DiaSorin S.p.A., Stillwater, MN or Linco Research, Inc., St. Charles, MO).
Data analysis. Plots of body weight or normalized caloric intake versus PD were compared using a repeated-measures analysis of variance (ANOVA) (SPSS, Chicago, IL). Means were compared by a t test or ANOVA with Tukey's post hoc comparison of means (OriginLab, Northampton, MA). Linear fits were obtained by linear regression. Data are presented as mean Ϯ standard error of the mean (SEM). Statistical significance was set at p Ͻ 0.05.
RESULTS
Juvenile Sprague-Dawley rats gained weight more slowly on a KD. We fed juvenile Sprague-Dawley rat littermates a KD or SD for 2 wk. We chose juvenile rats because younger animals are better adapted for ketosis (14) . The KD chow was the same chow used in several other rodent studies (6, 7, 15) . Rats tolerated the KD without difficulty. They appeared as healthy and active as their littermates fed the SD.
The littermates on the KD gained weight significantly more slowly than their siblings fed the SD as noted previously (6,7) (Fig. 1A) . Heart, liver, and kidney wet weights were 33% to 48% lower while brain mass was preserved after 2 wk on the KD (Fig. 1, B-E) . Aside from differences in mass, organs from rats fed the KD were not grossly different from those fed the SD except for the liver being fatty. To determine whether the effect of the KD on body weight was reversible, we placed rats on the SD from PD 21 to PD 25, the KD diet from PD 26 to PD 30, and the SD from PD 31 to PD 35. These animals had a slower growth rate while on the KD that reversed on return to the SD (Fig. 1A) . Interestingly, rats on the KD had higher normalized caloric intakes than those on the SD (Fig. 1F) . Thus, the KD reversibly slowed weight gain including that of lean body mass in juvenile rats while maintaining brain growth.
Increased serum leptin in juvenile Sprague-Dawley rats fed a KD. One mechanism by which the KD could slow weight gain is by altering serum leptin, insulin, ghrelin, and cortisol levels, which are hormones involved in regulating energy homeostasis (8) . We hypothesized that the KD slows weight gain by increasing leptin, increasing insulin, decreasing ghrelin, or decreasing cortisol levels.
Rats on the KD for 2 wk had 10-fold higher midday serum levels of ␤HB and 30% lower glucose levels than rats on the SD ( Fig. 2A and B) . The elevated ␤HB levels indicated that the KD produced ketosis. The lower glucose was expected since low carbohydrate diets can lower blood glucose in humans (5, 16) . Rats on the KD also had 140% higher leptin levels, 72% lower insulin levels, and slightly increased cortisol levels but similar ghrelin levels at midday compared with rats on the SD (Fig. 2C-F) . Five days on the KD produced smaller increases in serum ␤HB and leptin than 2 wk on the KD, with the changes being significant and reversing upon return to the SD ( Fig. 2A and F) . Although low-protein diets also slow weight gain, decrease insulin levels, and can increase leptin levels (17, 18) , they increase ghrelin levels (19) , suggesting that our results do not arise solely from the lowprotein content of the KD. Of the hormonal changes observed, only the increase in leptin could slow weight gain.
We examined how serum ␤HB and leptin varied with weight because of the known relationship between these parameters. Obese humans fed a low-carbohydrate diet experience greater weight loss with higher ␤HB levels (4). For both the SD and the KD, the rats with the highest ␤HB levels on the day of sacrifice weighed the least (Fig. 2G) . In rodents, serum leptin levels correlate with body mass index (20) . Although weight and leptin levels did not correlate in rats on the SD, rats having higher leptin levels on the KD weighed more (Fig.  2H) . For both the SD and the KD, neither insulin nor the leptin:insulin ratio correlated with weight.
Serum leptin does not increase in juvenile SpragueDawley rats fed a CD. In another experiment, we compared the weight growth curves and serum leptin levels in rats fed a KD, CD, or SD. We fed juvenile rat littermates a KD, CD, or SD for 2 wk. Rats on the KD and CD gained weight more slowly than their siblings fed the SD (Fig. 3A) . The fat mass of rats on the KD as a percentage of total mass was two to three times that of the rats on the SD or CD (Fig. 3B) . Rats on the KD had sixfold higher ␤HB than rats fed either the SD or CD (Fig. 3C ). Relative to the SD, the changes induced by the KD and CD in leptin levels correlated with the changes in fat mass (Fig. 3D) . Rats on the CD had access to chow just before sacrifice, as did the rats on the SD and KD. For the rats on the CD, access to chow just before sacrifice should produce maximal leptin levels (11) and may decrease ␤HB levels. These results demonstrate that the increase in serum ␤HB and leptin induced by the KD does not result from slower growth.
Juvenile ob/ob and db/db mice did not gain weight more slowly on a KD. We further examined the importance of leptin and ␤HB to the slower weight gain induced by the KD by using leptin deficient ob/ob and leptin receptor deficient db/db mice, which are both obese. If the KD requires leptin to slow weight gain, then it should not slow weight gain in ob/ob and db/db mice. Juvenile ob/ob and db/db mice fed the KD for 12-14 d gain weight at the same rate as ob/ob and db/db mice fed the SD (Figs. 4A and 5A ). These results suggest that the lower protein content and possible lower palatability of the KD do not completely explain the slower weight gain on the KD in rats and control mice (see below). The ob/ob and db/db mice maintained their weight gain despite having lower normalized caloric intakes on the KD (Figs. 4B and 5B). ob/ob mice on the KD were ketotic since they had 360% higher midday serum ␤HB levels than ob/ob mice on the SD (Fig. 4C) . As expected, ob/ob mice on the KD and the SD had comparable low levels of serum leptin immunoreactivity (Fig. 4D) , which probably reflects cross-immunoreactivity with the secretory form of the leptin receptor (21) . Likewise, db/db mice on the KD had 430% higher serum ␤HB levels and tended to have higher serum leptin levels than db/db mice on the SD (Fig. 5C and D) . The much higher leptin levels in db/db mice compared with control mice (see below) are expected (20) . These results suggest that the KD requires leptin and its receptor to slow weight gain.
The background strain of the ob/ob and db/db mice did not influence the effects of the KD. C57BL/6J (background strain for ob/ob mice) and C57BLKS/J (background strain for db/db mice) mice fed the KD gained weight more slowly than those fed the SD (Figs. 4A and 5A ). The KD decreased normalized caloric intakes in the C57BLKS/J but not in the C57BL/6J mice (Figs. 4B and 5B). The KD increased midday serum ␤HB levels in C57BL/6J mice by 10-fold and in C57BLKS/J mice by sixfold (Figs. 4C and 5C ). The KD increased serum leptin levels by at least 130% in C57BL/6J and C57BLKS/J mice (Figs. 4D and 5D ). 
ROLE OF LEPTIN IN A KETOGENIC DIET

DISCUSSION
We reproduced the KD induced slower weight gain in epileptic children in several strains of juvenile rats and mice. Animals on the KD had higher serum leptin levels, lower insulin levels, slightly increased cortisol levels, and similar ghrelin levels compared with animals fed the SD. Only the change in leptin is consistent with slower weight gain. The failure of a KD to slow weight gain in ob/ob and db/db mice supports a role for leptin in this process.
The metabolic and hormonal effects of the KD appear to provide the brain with conflicting information regarding energy status. The high leptin levels indicate an energy-replete state and probably reflect a relative increase in fat mass, which correlates with leptin levels (20) . Although another study concurs with our observation of higher leptin and lower insulin levels in KD-fed rats compared with SD-fed rats (22), we cannot explain the contrasting observations in humans with rheumatoid arthritis or type 2 diabetes who exhibit lower leptin levels on a KD (16, 23) . The lower insulin levels on a KD signal lower energy supplies and may result from decreased carbohydrate intake or increased insulin sensitivity (16, 22) . The resulting change in the leptin:insulin ratio may have a role in the slower weight gain because leptin and insulin levels typically change in the same direction (8) . The inverse relationship between ␤HB and weight suggests an important role for ketosis. The observation that rodents on nonketotic, high-fat diets gain weight faster than those on ketotic, high-fat diets supports this idea (22, 24, 25) . Furthermore, exogenously administered ␤HB causes weight loss (26) . Despite these observations, our results suggest that ketosis alone cannot slow weight gain because the KD caused ketosis in ob/ob and db/db mice without slowing weight gain. We do not know the reason for this discrepancy, but ␤HB may require leptin to alter energy balance. Overall, our results indicate that an intact leptin signaling system is necessary and that ketosis is insufficient for the KD to slow weight gain.
Our results differ from those of a recent study that found increased ghrelin levels in rats fed a KD (22) . We might predict such an increase because ghrelin levels rise in association with the slower weight gain observed in rats on proteinrestricted diets (19) . Although the low protein content of the KD we used may have contributed to our findings (7), the lack of a change in ghrelin and three other observations suggest that it is not the only factor involved. First, the KD maintained normal weight gain in ob/ob and db/db mice. Second, rats fed the KD showed relatively well-preserved lean mass when expressed as a percentage of body mass. Third, peak leptin levels on the CD did not exceed trough leptin levels on the SD despite the slower weight gain on the CD.
Ultimately, the KD must increase energy expenditure over energy intake to slow weight gain. The KD had variable effects on normalized caloric intake despite consistently slowing weight gain. It decreased caloric intake in C57BLKS/J, 416 db/db, and ob/ob mice, had no effect on caloric intake in C57BL/J6 mice, and increased caloric intake in SpragueDawley rats. Although the oily consistency of the KD chow made caloric intake measurements difficult, overall our findings suggest that the KD can decrease food intake and increase energy expenditure, which are known effects of leptin (8) .
Our results support the hypothesis that the KD exerts its anticonvulsant effects by activating a variety of potassium channels via the metabolic changes it induces (27) . We speculate that the KD-induced rise in serum leptin increases brain leptin levels because brain levels are proportional to serum levels (28). We expect a diffuse increase in brain levels because leptin transporters exist throughout the brain (28) and leptin increases throughout the brain when administered exogenously (29) . Leptin can act as an anticonvulsant throughout the brain because leptin receptors exist throughout the brain (28) and activate calcium-activated potassium channels (9) . However, the decline in insulin may counteract some of the effects of the rise in leptin because insulin activates the same channel (10) . In summary, we hypothesize that the KD produces a net anticonvulsant effect in part because increased brain leptin activates potassium channels. This mechanism may be unique among antiepileptic drugs, which do not increase leptin independent of weight gain (30 -32) . Our results do not exclude leptin modulation of neuronal or glial energy homeostasis or other mechanisms involving the complex metabolic and cellular effects of the KD from contributing to its anticonvulsant properties (27) .
Despite our focus on leptin, other neurohormones may contribute to the anticonvulsant and weight effects of the KD. For example, the increased cortisol levels we found in rats on the KD mirrors the increase seen in children on the KD and may contribute to the anticonvulsant effect of the diet (33) . Others have considered the possibility that changes in neuropeptide Y and galanin expression contribute to the effects of the KD, but the diet does not change their brain mRNA levels (34) . Rather than excluding a contribution of other neurohormones, our results indicate that studying KD-induced changes in neurohormones involved in energy homeostasis may help elucidate the mechanisms underlying the anticonvulsant and weight effects of the KD.
